China To Inspect Drug Ex-factory Prices: Good News Or Bad News?

By Jialing Dai / Email the Author / PharmAsia News Dec. 1, 2011 2:59 PM GMT
China / Word Count: 649 / Article # 28111201001

Executive Summary

China’s powerful National Development and Reform Commission To Launch Investigations On Pricing Disparities

Purchase this Article

$35.00 Buy Now

For $35.00, purchase this 649-word article and receive immediate online access. 100% Satisfaction Guarantee.

Already a Subscriber?

Log in for complete access.

Questions?

Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.

+ Show All | – Hide All

Offers & Events

Topics Covered in this Article

Click a keyword for related articles.
Subjects
Commercial
Pricing Strategies
Regulatory
Regions
Asia-Pacific
China

Log In

Email Address

Password

Remember Me

Forgot your password?

Don’t Have an Account?

If your employer has a site license, create your account to begin using it. Simply click ‘Create An Account’ button below to register now.

Otherwise, please explore our free content subscriptions.

Create an account

Enter the email address associated with your account and a temporary password will be sent to you.

Email Address

Need help? Contact us at (800) 332-2181, +1 (908) 547-2159, or custcare@elsevier.com

Email Article

* Required field

* To:

For multiple recipients, separate email addresses with a semi-colon.

* Your Name:

* Your Email:

Subject: China To Inspect Drug Ex-factory Prices: Good News Or Bad News?

* Add a personalized message to your email:

Please Note: Only individuals with subscriptions to PharmAsia News will be able to access the full article. All other readers will be directed to the abstract and may purchase the article.

or Cancel